Integrated Tissue Dynamics - INTIDYN's services benefit our clients performing Clinicial Human research in Phases 1 through 3.
Phase 1 - Clinical Research Services:
Based on preclinical research, our unique expertise in evaluating human skin and nerves will help our clients anticipate inclusion and exclusion criteria for your Phase 1 studies. INTIDYN's Chemomorphometric Analysis (ITD-CMA) will provide our clients with a sensitive unbiased, multi-factorial method for detecting potential side-effects, assessing their clinical impact, and adjusting therapeutic dosages to safe levels. Our expertise can help our clients develop exclusion criteria for your Phase 2 studies.
Phase 2 - Clinical Research Services:
Based on Pre-clinical and Phase 1 studies, our unique expertise evaluating human skin and nerves can assist our clients in project design by helping our clients identify those subjects that are most likely to benefit from a therapeutic without being prone to side-effects. INTIDYN's Chemomorphometric Analysis(ITD-CMA) can then provide our clients with a sensitive unbiased, multi-factorial method for detecting the efficacy of your therapeutic and for adjusting dosages to maximize their effect. ITD-CMA can also help verify efficacy of novel target diseases that are currently not approved by the FDA (i.e. off-label usage).
Phase 3 - Clinical Research Services:
ITD-CMA provides a time sensitive, high throughput ongoing assessment of the efficacy and toxicity of our clients’ therapeutics.